Ocariza, Kakashca Faye L.
HRN: 24-37-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2024
CEFTRIAXONE 1G (VIAL)
01/05/2024
01/11/2024
IV
800mg
OD
PCAP Severe
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes